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brain injury andbrain healthof servicemembers and agingvet-
erans. The wars in Iraq and Afghanistan have been character-
ized by injuries from improvised explosive devices, including
nearly a quarter million cases of mild traumatic brain injury
(mTBI) since 2000 [1]. Brain injuries represent a higher pro-
portion of injuries compared with previous conflicts such as
the Vietnam War, in part because the modern body armor
has altered the pattern of combat injuries. Although most pa-
tients withmTBI recover, persistentmTBI can include incapa-
citating multisensory and neuropsychological symptoms and
other delayed problems include depression and behavioral
dysfunction [2–4]. In 2011, there were 1,542,625 veterans
receiving compensation for tinnitus and hearing loss
problems alone. These injuries are combined with high rates
of psychological trauma, including . 100,000 new combat-
related cases of posttraumatic stress disorder (PTSD) in
service members since 2000 and more than one half million
veterans from all wars receiving compensation for unresolved
PTSD in 2011 [1].As a result of theVietnamandfirstGulfWar
experiences, PTSD is better recognized and treated than ever
before,whereas someKoreanWarveterans are onlynowbeing
diagnosed for long untreated conditions [5]. Stigma has also
been reduced for some mental health issues. Military leaders
have helped to change a culture that previously labeled
PTSD as a personal failing. When General Peter Chiareilli
was the Vice Chief of Staff of the Army, he initiated Army-
wide educationcampaigns on suicide andmental health issues,
promoting a new perspective that it was possible for anyone to
break under stress, and it was important for soldiers to seek
medical help, be restored to full function, and continue their
military career [6]. Just as soldiers with lower limb amputa-
tions have now returned to function with prosthetic legs and
are leading troops in Afghanistan [7], soldiers who have suf-
fered fromPTSD have also been treated and continue to serve.
These new priorities have been substantially promoted by*This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).
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vice members and veterans.
The first Gulf War in 1990 to 1991 launched this brain
health focus. Of a large deployed force of 697,000 troops,
there were 147 combat deaths and relatively few injuries
[8], unmasking a form of chronic multisymptom illness now
referred to as “Gulf War Syndrome” characterized by pain,
fatigue, and neurocognitive symptoms that have probably pre-
sented in some form after every major conflict [9–11]. To
ensure that the Department of Defense (DoD) and Veterans
Affairs (VA) met the needs of veterans with undiagnosed
symptoms of Gulf War Illness, Congress provided .$150
million for medical research to investigate virtually every
testable hypothesis concerning deployment health [12,13]
and more funding for medical care. The findings led to new
health monitoring policies, a new emphasis on electronic
medical records and exposure databases, health risk
communications, and major investigations into neurologic
health and neurotoxic threats [10]. In 2006, there was a resur-
gence of Congressional interest in military health-care needs
and Congress provided $300million for research on traumatic
brain injury (TBI) and PTSD (FY2007), followed by .$100
million each year to continue the research (.$1 billion to
date). In June 2008, the Secretary of Defense, Robert Gates,
directed the military services to refocus the medical research
program to advance “the state of medical science in those
areas of most pressing need and relevance to today’s battle-
field experience, particularly in the area of mental health
and traumatic brain injury” [14]. In FY2010, there was an
additional large increase in the Pentagon’s annual budget
for medical research ($400million/y). These huge funding in-
creases for medical research for service members and veter-
ans have largely focused on near term health-care needs of
injured and ill service members [15], but other Congressional
appropriations provided for longer term concerns.
There is a large, parallel, DoD-funded effort on investi-
gation of long-term consequences of war-related brain
injury (Fig. 1). The costs of delayed action, in terms of
quality of life and post hoc medical research investigations,
have been well demonstrated in the continuing investiga-
tions of Vietnam veterans exposed to Agent Orange and
the Gulf War Illness cohorts. Congress prodded the
DoD and VA into action on militarily-relevant Parkinson’s
disease research with annual funding for the Army’seserved.
Fig. 1. DoD funding profile for Gulf War illness (GWI), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease (AD) medical
research programs that preceded and now parallel major funding surges exceeding $1 billion in traumatic brain injury (TBI) and psychological health research
since 2007.
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program starting in 1997 (totaling $372 million to date)
and with the establishment of the VA Parkinson’s Disease
Research, Education, and Clinical Centers in 2001 with
an initial focus on deep brain stimulation therapy for veter-
ans. Connections between head trauma and longer term
risks for dementia, Alzheimer’s disease (AD), and Parkin-
son’s disease were already suspected, with highly visible
cases in boxers and football players. Parkinson’s disease
also had a strong association with neurotoxic chemical ex-
posures with overlapping chemicals of concern in the in-
vestigations of Gulf War illness, as highlighted in this
issue by Carlie Tanner and her colleagues. After intensive
epidemiologic investigation of amyotrophic lateral scle-
rosis (ALS) in Gulf War veterans [16], the VA determined
that ALS was a Gulf War deployment-associated disease
and provided compensation to affected veterans, and
Congress provided funding for a new DoD ALS research
program. More recently, Congress has provided annual
funding for a militarily-relevant AD program (totaling
$51 million in 3 years). The Vietnam veterans Alzheimer’s
Disease Neuroimaging Initiative (ADNI) study, described
in this issue, was the first effort established under this
new program, seizing the opportunity to leverage the exist-
ing ADNI research infrastructure to identify potential long-
term AD risks associated with PTSD or TBI originating
with service in the Vietnam War. Most recently, the VA
has made AD and Parkinson’s disease presumptive for
TBI connected with military service [17].
The association of psychological trauma, depression, and
mental resilience in the development of dementia and neuro-
degenerative diseases has emerged in recent research but is
still complicated and awaiting mechanistic explanations.
Depressive illness is an important concern in service mem-bers and has been related to brain injury and psychological
stress as highlighted in articles in this issue. Chronic stress
conditions, such as being held as a prisoner of war, have
also been associated with Parkinson’s disease [18] and
with AD and other dementias (described in this issue by Me-
ziab et al.). The mechanistic links between depression and
neurodegenerative disease are beginning to fill in with the
foundational Army-funded work of researchers such as
Paul Greengard [19,20]. The Army Parkinson’s program
preceded the huge budget increases for TBI and
psychological health research by a decade and provided a
foundation of research on military risk factors such as TBI
and chemical exposures, as well as development of tools
such as the neuropsychological test used by the DoD [21]
and development of biomarkers of neurodegenerative dis-
ease (both described in this issue by Vincent and Fiandaca).
The Parkinson’s program and the other militarily-relevant
disease programs (ALS and AD) have been particularly use-
ful in advancing research that served both military medical
needs and neurodegenerative disease objectives. These pro-
grams highlight changing military medical research needs,
influenced by changing problems and biomedical advances
especially related to common medical diagnostic and treat-
ment needs across the wide continuum of service members
and veterans. The development of tau protein neuroimaging
capability is one important example of a common tool that
may be important to breakthrough diagnostic capability for
young head-injured soldiers, as well as injured veterans (ar-
ticles by McKee and Villemagne in this issue).
Much of the DoD clinical research funding has gone to VA
researchers where the critical research capabilities, expertise,
and relevant patient populations reside. VA research centers
are recognized as the national resource for treatment and reha-
bilitation of deployment-related brain injury and illness and
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ated for TBI and behavioral health, more than twice the
amount spent in DoD clinical research studies. The DoD con-
tinues to institute improvements in protection of servicemem-
bers, including avoidance of neurotoxic chemical exposures,
development of brain injury models to guide helmet design,
and programs to promote psychological resilience; develop
strategies for brain health monitoring throughout a service
member’s career; and validation of assessment methods to
detect mTBI, PTSD, and other behavioral health changes
[15]. These DoD brain health protection strategies include
consideration of long-term consequences for veterans from
a continuum of military risk factors. Just as DoD research
demonstrated that stress fractures prevalent in basic training
were associated with the same risk factors as osteoporosis
in aging veterans, brain health and resilience are likely asso-
ciated with the type of brain aging that military veterans will
face. When the VA and the DoD finally resolve issues con-
cerning the President’s request for the creation of a virtual
lifetime electronic record [22], special registries will be a
thing of the past and many interrelated etiologic factors,
including medical history and genetics, military exposures
and experiences, and health outcomes will become clearer.
The current Surgeon General of the Army, LTG Patricia Hor-
oho, is leading the services on a new forward-looking health
path, focusing on brain health and resilience of service mem-
bers through modifiable health habits as seemingly pedestrian
as exercise, nutrition, and sleep [23]. Articles in this issue
address lifestyle factors and specifically sleep and smoking
roles in later brain health status.
This special issue presents current concepts on the contin-
uum between military risk factors of current importance and
high prevalence and development of neurodegenerative dis-
ease in veterans. The articles illustrate the highly collabora-
tive nature of this DoD and VA cooperation to better prevent
and treat brain injuries in young service members, with the
potential to dramatically reduce the risk for later neurode-
generative disease in military veterans.
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